Missing/wrong data?
Log in to edit
Coformulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection (GS-US-380-1490): a randomised, double-blind, multicentre, phase 3, non-inf
scientific article published on 31 August 2017
Author/s
author: Hans-Jürgen Stellbrink, Andrea Antinori, Paul E Sax, Kimberly Workowski
Work details
Publication date
August 31, 2017
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.